Lack of comprehensive cost-benefit evaluation for medical products in Costa Rica disadvantages UK exporters
Trade barrier summary
Government purchases of medicines and medical products do not follow a comprehensive cost-benefit evaluation of the product. This makes it difficult for UK companies looking to introduce new and innovative technologies and treatments in the market.
Sectors affected
- Healthcare services
- Medical devices and equipment
Resolved
No
Date reported
23 March 2020
Last updated
26 November 2021
Public ID
PID-G22RYG
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.